Johan Verhelst

2.7k total citations
29 papers, 2.0k citations indexed

About

Johan Verhelst is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Johan Verhelst has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Johan Verhelst's work include Growth Hormone and Insulin-like Growth Factors (20 papers), Pituitary Gland Disorders and Treatments (17 papers) and Adrenal and Paraganglionic Tumors (10 papers). Johan Verhelst is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (20 papers), Pituitary Gland Disorders and Treatments (17 papers) and Adrenal and Paraganglionic Tumors (10 papers). Johan Verhelst collaborates with scholars based in Belgium, Sweden and Austria. Johan Verhelst's co-authors include Roger Abs, Dominique Maiter, Charles Mahler, Kristien Van Acker, Albert Beckers, Maria Kołtowska‐Häggström, Jan Verlooy, Frank Nobels, Anders Mattsson and Jean-Luc Coolens and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Cancer.

In The Last Decade

Johan Verhelst

29 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Verhelst Belgium 21 1.6k 600 239 198 196 29 2.0k
Geneviève Sassolas France 21 856 0.5× 307 0.5× 167 0.7× 63 0.3× 420 2.1× 33 1.5k
Bartolomeo Merola Italy 32 2.7k 1.7× 1.0k 1.7× 339 1.4× 318 1.6× 395 2.0× 96 3.3k
François Girard France 15 698 0.4× 243 0.4× 116 0.5× 40 0.2× 66 0.3× 22 1.2k
G Pieters Netherlands 27 1.3k 0.8× 420 0.7× 129 0.5× 70 0.4× 189 1.0× 80 1.9k
P M Foy United Kingdom 18 206 0.1× 269 0.4× 88 0.4× 354 1.8× 209 1.1× 29 1.8k
Hans Hedlund Sweden 30 860 0.5× 331 0.6× 350 1.5× 47 0.2× 124 0.6× 73 2.2k
Andrea L. Utz United States 14 1.5k 1.0× 581 1.0× 227 0.9× 36 0.2× 298 1.5× 24 1.9k
A Gómez-Pan Spain 23 954 0.6× 491 0.8× 155 0.6× 95 0.5× 525 2.7× 77 2.0k
Lawrence F. Borges United States 15 447 0.3× 363 0.6× 165 0.7× 20 0.1× 104 0.5× 31 1.4k
P. T. Pullan Australia 13 377 0.2× 188 0.3× 91 0.4× 55 0.3× 113 0.6× 30 774

Countries citing papers authored by Johan Verhelst

Since Specialization
Citations

This map shows the geographic impact of Johan Verhelst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Verhelst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Verhelst more than expected).

Fields of papers citing papers by Johan Verhelst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Verhelst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Verhelst. The network helps show where Johan Verhelst may publish in the future.

Co-authorship network of co-authors of Johan Verhelst

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Verhelst. A scholar is included among the top collaborators of Johan Verhelst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Verhelst. Johan Verhelst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuen, Kevin C.J., Anders Mattsson, Pia Burman, et al.. (2017). Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement. The Journal of Clinical Endocrinology & Metabolism. 103(2). 768–777. 22 indexed citations
2.
Verhelst, Johan, Brigitte Velkeniers, Dominique Maiter, et al.. (2012). Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly. European Journal of Endocrinology. 168(2). 177–184. 20 indexed citations
3.
Abs, Roger, Anders Mattsson, Maria Thunander, et al.. (2012). Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. European Journal of Endocrinology. 168(3). 297–305. 42 indexed citations
4.
Verhelst, Johan, Anders Mattsson, Anton Luger, et al.. (2011). Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. European Journal of Endocrinology. 165(6). 881–889. 53 indexed citations
5.
Berger, Jan, et al.. (2009). Flexion contractures in secondary adrenal insufficiency. Clinical Rheumatology. 29(1). 115–117. 5 indexed citations
6.
Verhelst, Johan & Roger Abs. (2009). Cardiovascular risk factors in hypopituitary GH-deficient adults. European Journal of Endocrinology. 161(suppl_1). S41–S49. 56 indexed citations
7.
Verhelst, Johan, et al.. (2008). Modification of hormonal secretion in clinically silent pituitary adenomas. Pituitary. 12(1). 80–86. 28 indexed citations
8.
Abrams, Pascale, Orsalia Alexopoulou, Roger Abs, Dominique Maiter, & Johan Verhelst. (2007). Optimalization and cost management of lanreotide-Autogel therapy in acromegaly. European Journal of Endocrinology. 157(5). 571–577. 24 indexed citations
9.
Verhelst, Johan, et al.. (2006). Cardiomyopathy and thyrotoxicosis. Acta Cardiologica. 61(1). 115–117. 10 indexed citations
10.
Abs, Roger, Anders Mattsson, Bengt‐Åke Bengtsson, et al.. (2005). Isolated growth hormone (GH) deficiency in adult patients: Baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone & IGF Research. 15(5). 349–359. 70 indexed citations
11.
12.
Verhelst, Johan & Roger Abs. (2003). Hyperprolactinemia. PubMed. 2(1). 23–32. 80 indexed citations
13.
Verhelst, Johan & Roger Abs. (2002). Long-Term Growth Hormone Replacement Therapy in Hypopituitary Adults. Drugs. 62(16). 2399–2412. 43 indexed citations
14.
Verhelst, Johan, Roger Abs, Dominique Maiter, et al.. (1999). Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients. The Journal of Clinical Endocrinology & Metabolism. 84(7). 2518–2522. 327 indexed citations
15.
Verhelst, Johan, M. Vandeweghe, Jean Mockel, et al.. (1997). Two years of replacement therapy in adults with growth hormone deficiency. Clinical Endocrinology. 47(4). 485–494. 81 indexed citations
16.
Verhelst, Johan, Albert Beckers, & Roger Abs. (1995). The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman. Fertility and Sterility. 64(5). 969–971. 3 indexed citations
17.
Abs, Roger, Frank Nobels, Johan Verhelst, et al.. (1993). Hyperfunctioning unilateral adrenal macronodule in three patients with Cushing's disease: hormonal and imaging characterization. European Journal of Endocrinology. 129(4). 284–290. 9 indexed citations
18.
19.
Abs, Roger, et al.. (1991). Hyperfunctioning metastatic follicular thyroid carcinoma in pendred's syndrome. Cancer. 67(8). 2191–2193. 22 indexed citations
20.
Verhelst, Johan, Patrick Druwé, P. Van Erps, Louis Denis, & Charles Mahler. (1989). Use of ketoconazole in the treatment of a virilizing adrenocortical carcinoma. European Journal of Endocrinology. 121(2). 229–234. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Sassolas Breakdown of academic impact, for papers by Bartolomeo Merola Breakdown of academic impact, for papers by François Girard Breakdown of academic impact, for papers by G Pieters Breakdown of academic impact, for papers by P M Foy Breakdown of academic impact, for papers by Hans Hedlund Breakdown of academic impact, for papers by Andrea L. Utz Breakdown of academic impact, for papers by A Gómez-Pan Breakdown of academic impact, for papers by Lawrence F. Borges Breakdown of academic impact, for papers by P. T. Pullan
Rankless by CCL
2026